Hemolytic uremic syndrome (HUS) is a condition that affects the blood vessels in your kidneys. When the vessels are damaged, they form clots that block the kidney's regular filtering system, leading ...

Banerjee R, Hersh AL, Newland J, et al; on behalf of the Emerging Infections Network Hemolytic-Uremic Syndrome Study Group Most (92%) of the cases were confirmed by culture with the remaining 8% being ...

Please provide your email address to receive an email when new articles are posted on . Researchers reviewed the efficacy of ravulizumab based on 2-year data from two phase 3, single-arm studies. eGFR ...

Both hemolytic uremic syndrome (HUS) and thrombotic thrombocytopenic purpura (TTP) are characterized by thrombotic microangiopathy (TMA), affecting mainly the kidney and brain, respectively. Diagnosis ...

Please provide your email address to receive an email when new articles are posted on . Registry data showed efficacy of ravulizumab was similar to that of eculizumab. No unexpected adverse events ...

A 6-week-old child with acute urinary tract infection caused by Shiga toxin-producing Escherichia coli (STEC) O5:H- developed hemolytic-uremic syndrome (HUS). Molecular and phenotypic analysis of the ...

Argentina recorded almost 50 hemolytic uremic syndrome (HUS) cases in the first six weeks of 2024. HUS is a severe complication associated with E. coli infections that causes kidney failure. The 49 ...

LONDON--(BUSINESS WIRE)--Technavio has announced their latest pipeline analysis report on the drug pipeline for the atypical hemolytic uremic syndrome. The report includes a detailed analysis of the ...

- At 26 weeks, 54% of adults and 71% of children treated with ULTOMIRIS demonstrated Complete Thrombotic Microangiopathy (TMA) Response - Atypical HUS affects both adults and children and many ...

HUS is a condition that damages the blood vessels in the kidneys. This may lead to blood clots and, in severe cases, kidney failure. Symptoms include vomiting, diarrhea, abdominal pain, and fever.

The association of acute hemolytic anemia, thrombocytopenia and renal failure was described by Casser et al. 1 in 1955. Since that time, several hundred cases have been reported, mainly in children.